As a first-time investor, it can be daunting trying to figure out where to put your money. But don’t worry, we’ve got you covered. Join us as we cover different types of investments!

What are the most popular types of investments? | Get Rich Slow Club

Whilst none of us are the next Warren Buffett, we have the ability to "own a piece of America", as he often suggests. For this reason, we're sharing the 10 most most popular US stocks on Pearler. 

Check out Pearler's most popular US stocks

Think of community data as a compass: you can choose any stock you want, but our community keeps pointing in the same general direction - simple, diversified, and cheap ETFs. Let's take a look at the 10 most popular ETFs on Pearler.

These are Pearler's most popular ETFs

EGShares India Consumer ETF (INCO:US) Share Price | Pearler

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

The iShares S&P 500 ETF seeks to track the investment results of an index composed of large-capitalisation U.S. equities.

iShares S&P 500 Etf

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). These are mostly large and established Australian companies. It is a popular choice among passive individual investors who don't have the time or the expertise to actively invest in stocks.

Vanguard Australian Shares Index Etf

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. The other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib) and ICLUSIG (ponatinib), as well as other clinical development programs. Its Dermatology commercial franchise is comprised of OPZELURA (ruxolitinib) cream.

Incyte Corporation

Inhibrx, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of biologic therapeutic candidates in oncology and orphan diseases. Its clinical pipeline includes therapeutic candidates, such as INBRX-101, INBRX-109, INBRX-105 and INBRX-106. INBRX-101 is an engineered recombinant human alpha-1 antitrypsin fragment crystallizable (AAT-Fc) fusion protein therapeutic candidate that the Company is developing for the treatment of patients with Alpha-1 Antitrypsin Deficiency (AATD) and acute Graft-versus -host-disease (aGvHD). INBRX-109 is an engineered tetravalent therapeutic candidate targeting death-receptor 5 (DR5), a TNFRSF member, also known as tumor necrosis factor-related apoptosis-inducing ligand or TRAIL receptor 2. INBRX-105 is a conditional tetravelent PD-L1 targeted 4-1BB agonist that is being investigated as a single agent and in combination with Keytruda in patients with locally advanced or metastatic solid tumors.

INHIBRX INC

The investment seeks investment results that correspond to the price and yield performance of the Indxx India Consumer Index. The fund will invest at least 80% of its net assets in Indian consumer companies included in the INCO underlying index and the advisor generally expects to be substantially invested at such times, with at least 95% of its net assets invested in these securities. The INCO underlying index is a maximum 30-stock free-float adjusted market capitalization-weighted index designed to measure the market performance of companies in the consumer industry, as defined by Indxx's proprietary methodology, in India. It is non-diversified.

EGShares India Consumer ETF

Vanguard High Dividend Yield Index Fund is an open-end investment company. The Fund seeks to track the performance of an index that measures the investment return of common stocks of companies that are characterized by high dividend yield. Investor Shares are available to any investor who meets the fund’s minimum purchase requirements. ETF Shares are purchased and sold through a broker. The Fund offers two classes of shares: investor Shares and exchange traded fund (ETF) Shares. The Fund focuses on investment approach designed to track the performance of the FTSE High Dividend Yield Index. The Fund's investment advisor is The Vanguard Group, Inc.

High Dividend Yield ETF Vanguard

WisdomTree India Earnings Fund (The Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree India Earnings Index. The Index measures the performance of profitable companies incorporated and traded in India that are eligible to be purchased by foreign investors and that meet specific criteria developed by WisdomTree Investments.

India Earnings Wisdom Tree ETF

iShares MSCI Indonesia ETF, formerly iShares MSCI Indonesia Investable Market Index Fund (the Fund), is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Indonesia Investable Market Index (the Underlying Index). The Underlying Index is a free-float adjusted market capitalization-weighted index designed to measure the performance of equity securities in the top 99% by market capitalization of equity securities listed on the stock exchanges in Indonesia. The Fund invests at least 90% of its assets in the securities of the Underlying Index and in a depositary receipts. The Underlying Index is sponsored by an organization (the Index Provider), that is independent of the Fund and BlackRock Fund Advisors (BFA). BFA serves as the investment advisor of the Fund.

Indonesia MSCI ETF iShares

iShares MSCI Brazil Capped Index Fund (the Fund), formerly iShares MSCI Brazil Index Fund, seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of publicly traded securities in the Brazilian market, as measured by the MSCI Brazil Index (the Index). The Index seeks to measure the performance of the Brazilian equity market. It is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. The Fund invests in sectors, such as financials, energy, materials, consumer staples, utilities, consumer discretionary, telecommunication services, industrials, information technology and healthcare. BlackRock Fund Advisors (BFA) serves as the investment adviser to the Fund.

Brazil Capped ETF MSCI iShares

The Fund seeks to provide investment results that correspond generally to the price and yield performance of the Indxx Global Cloud Computing Index. The Underlying Index is designed to provide exposure to exchange-listed companies that are positioned to benefit from the increased adoption of cloud computing technology.


INCO

Buy

👑 Overview

📈

N/A

Annual Growth

🌏

1

Pearlers Invested

Key information

🔎 Fund Overview

Price History*

Unsure how much or often to invest?

🗓️ Investing frequency calculator

💵 Investing amount calculator

⏱️ Investing duration calculator

💵

6.50 AUD*

Purchase Fee

💼

N/A

Management Fee

💸

Want to know the long term costs?

Calculate the historic long term costs to hold your investments

Technical Info

$49.41

How our community is investing

1

N/A

N/A

N/A

898 days

INCO investor breakdown

💵 Income of investors

50%

50%

👶 Age of investors

100%

🙋 Legal gender of investors

100%

$102.38 USD

Find Out More

$33.33 USD

Find Out More

$23.79 USD

Find Out More

$29.94 USD

Find Out More

$18.12 USD

Find Out More

$62.58 USD

Find Out More

$24.16 USD

Find Out More

Buy